Cargando…
Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment
Tocilizumab (TCZ) has been administered in SARS-CoV-2 pneumonia but the factors associated with mortality before and after treatment remain unclear. Cox regression models were used to estimate the predictors of time to death in a cohort of hospitalized patients with COVID-19 receiving TCZ. In additi...
Autores principales: | Sarabia De Ardanaz, Luis, Andreu-Ubero, Jose M., Navidad-Fuentes, Miriam, Ferrer-González, Miguel Ángel, Ruíz del Valle, Victor, Salcedo-Bellido, Inmaculada, Barrios-Rodríguez, Rocío, Cáliz-Cáliz, Rafael, Requena, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281134/ https://www.ncbi.nlm.nih.gov/pubmed/34276355 http://dx.doi.org/10.3389/fphar.2021.620187 |
Ejemplares similares
-
Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
por: Hernández-Cruz, Blanca, et al.
Publicado: (2016) -
Artritis reactiva con SARS-CoV-2 como desencadenante
por: Ruiz-del-Valle, Víctor, et al.
Publicado: (2022) -
Reactive arthritis with SARS-COV-2 as a trigger()
por: Ruiz-del-Valle, Víctor, et al.
Publicado: (2022) -
Biomarkers in DILI: One More Step Forward
por: Robles-Díaz, Mercedes, et al.
Publicado: (2016) -
Factors associated with the development of second primary tumours in head and neck cancer patients
por: Salcedo‐Bellido, Inmaculada, et al.
Publicado: (2022)